HSIC(Henry Schein, Inc.) 的财务报表:医疗保健,医药分销。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-25 | FY 截至 2022-12-31 | FY 截至 2023-12-30 | FY 截至 2024-12-28 | FY 截至 2025-12-27 |
|---|---|---|---|---|---|
| 营业收入 | $12.40B | $12.65B | $12.34B | $12.67B | $13.18B |
| 毛利润 | $3.67B | $3.83B | $3.86B | $4.02B | $4.11B |
| 营业利润 | $852.00M | $747.00M | $615.00M | $621.00M | $653.00M |
| 净利润 | $631.00M | $538.00M | $416.00M | $390.00M | $398.00M |
| 经营现金流 | $710.00M | $602.00M | $500.00M | $848.00M | $712.00M |
| 自由现金流 | $631.00M | $506.00M | $353.00M | $700.00M | $573.00M |
| 摊薄每股收益 | $4.45 | $3.91 | $3.16 | $3.05 | $3.27 |